U.S. Orthopaedic Partners (USOP), based in Jackson, Mississippi, has announced its plans to enter into a strategic partnership with Andrews Sports Medicine & Orthopaedic Center, based in Birmingham, Alabama.
U.S. Orthopaedic to Partner With Andrews Sports Medicine
USOP is a management services organization focused on orthopedic care. It was formed in 2020 by FFL Partners, LLC’s acquisition of Jackson, Mississippi-based Mississippi Sports Medicine and Orthopaedic Center. FFL Partners is a San Francisco, California-based private equity firm. According to USOP, the company “provides the full continuum of musculoskeletal treatment to patients in the Southeastern U.S.”
Andrews Sports Medicine, which was founded by the legendary Jimmie Andrews, has a team of 21 sports medicine physicians and orthopedic surgeons serving patients from six facilities in the greater Birmingham, Alabama area. Andrews Sports Medicine is arguably the leading sports medicine clinic in the United States and attributes at least some of its success to working with patients who have an “athletic mindset.”
Both companies have a strong educational focus whose fellowship training programs have “educated over 500 of the current leaders in orthopedic surgery and sports medicine over the last thirty [30] years.”
USOP Vice President of Mergers and Acquisitions Graham Young spoke with OTW about the partnership and said, “The reputational and clinical legacy that Andrews Sports Medicine has earned adds an exceptional new element to the U.S. Orthopaedic Partners network.”
Young continued, “The highly personalized nature of Andrews Sports Medicine has drawn us together to continue building one of the most comprehensive orthopedic care platforms in the evolving healthcare landscape.”
Through strategic partnerships, USOP supports the needs of practicing orthopedists while allowing them to maintain clinical autonomy and brand identity. USOP helps orthopedists focus on patient care and growth by managing accounting, taxes, information technology, facilities, and human resources paperwork.
While discussing the partnership’s goals for the remainder of 2021, Young informed OTW, “We are looking forward to growing our regional recognition and excellence and are proud to provide premier specialized care solutions for our patients who instill their trust into our expert practitioners.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.